Sankalp Rehabilitation Trust Opposition, Dolutegravir, (3865/Kolnp/2007)
No Annotations
Alert me when there are new annotations for this document
9 similar patent oppositions
-
Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai opposition, Cabotegravir, (637/KOLNP/2013)
Countries: India Date: 2019
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (7440/DELNP/2015)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202018020805)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)
Countries: India Date: 2015
-
Sankalp Rehabilitation Trust opposition, Telacebec, (8533/DELNP/2012)
Countries: India Date: 2020
-
Sankalp Rehabilitation Trust, Hepatitis C Coalition of Nagaland (HepCon) and Asia Network of Positive People (APN+) opposition, Sofosbuvir , (3658/KOLNP/2009)
Countries: India Date: 2014
-
Hepatitis Coalition, Nagaland (HepCon), Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai and Asia Pacific Network of Positive People (APN+), all of whom are represented by the Lawyers Collective opposition, daclatasvir, (853/DELNP/2009)
Countries: India Date: 2015